Guided Therapeutics’ LuViva device achieves regulatory approval for sale in India

2018-03-21 06:25:01

LuViva is a device that scans the cervix with light and uses spectroscopy for cervical cancer diagnosis.By Team ABLEGuided Therapeutics Inc. has received Regulatory Approval from the Indian Ministry of Health & Family Welfare to allow commercialization of the LuViva device and disposables. The Ministry concluded that the LuViva device is “Non Invasive” and as such is “not regulated under

Read more

Biogen pays $75 million to buy Pfizer’s neuropsychiatry drug asset

2018-03-21 06:24:08

Biogen will acquire PF-04958242, a first-in-class, Phase 2b ready AMPA receptor potentiator for cognitive impairment associated with schizophrenia from Pfizer. By Team ABLENasdaq-listed pharma giant Biogen Inc. has signed an agreement to acquire PF-04958242, a first-in-class, Phase 2b ready AMPA receptor potentiator for cognitive impairment associated with schizophrenia (CIAS) from Pfizer Inc. The

Read more

International Council of Biotech Associations unveils new website

2018-03-21 06:22:23

The new website aims to unite publicly available resources of ICBA members, providing a virtual library of materials ranging from economic and employment data to issue specific whitepapers. By Team ABLEThe International Council of Biotech Associations (ICBA), in which ABLE is an active member, has announced the launch of its internationalbiotech.org, a new website to support the organization’s m

Read more

Novartis expands alliance with Science 37 to advance virtual clinical trials program

2018-03-11 23:46:47

Novartis and Science 37 commit to launch up to 10 trials with increasing decentralization over three years, scaling to site-less model By Team ABLENovartis has announced an additional strategic alliance with Science 37, which is involved in decentralized clinical trial technology and design, to initiate up to 10 new clinical trials over the next three years. The studies will blend virtual and trad

Read more

Evotec, Sanofi intend to create an Evotec-led Infectious Disease Open Innovation R&D Platform

2018-03-11 23:44:35

The Evotec-led platform is open to academia, biotechnology and pharmaceutical companies, foundations, and government agenciesBy Team ABLEGermany’s Evotec AG and Sanofi have entered into exclusive negotiations for Evotec to accelerate infectious disease research and development through a new open innovation platform near Lyon, France.In support of this platform, Sanofi will licence most of its in

Read more

Lupin signs agreement with CSIR-NCL and DST

2018-03-11 23:43:40

Lupin has signed an agreement with CSIR-National Chemical Laboratory and Department of Science and Technology for conducting research on a continuous purification process development of a biosimilar monoclonal antibody therapeutic.By Team ABLEPharma major Lupin has signed an agreement with CSIR-National Chemical Laboratory (CSIR-NCL, Pune) and Department of Science and Technology, (DST, Delhi) for

Read more

National Conference on Technological Empowerment held on International Women’s Day

2018-03-11 23:41:02

On the occasion of International Women’s Day, the National Academy of Sciences, India, organized an event on empowering women in the science and technology fieldBy Team ABLEThe National Academy of Sciences, India (NASI), the oldest Science Academy of the country, had organized a two-day “National conference on the technological empowerment of women” on the occasion of International Women’s

Read more

DBT calls for applications under Tata Innovation Fellowship, 2017-18

2018-03-11 23:38:08

The fellowship is aimed at rewarding interdisciplinary work where major emphasis is on innovation and translational research with a potential towards commercialization.By Team ABLEApplications are invited for Tata Innovation Fellowship, a highly competitive scheme instituted by the Department of Biotechnology, Ministry of Science & Technology, Govt. of India to recognize and reward scientists

Read more

ExxonMobil\'s to introduce Algae Biofuel by 2025

2018-03-11 23:37:23

ExxonMobil Corporation XOM and Synthetic Genomics have initiated a new phase in their joint algae biofuel research program. Through the study, the company intends 10,000 barrels of algae biofuel per day by 2025. By Team ABLEExxonMobil Corporation XOM and Synthetic Genomics have initiated a new phase in their joint algae biofuel research program. Through the study, the company intends 10,000 barrel

Read more

Datar Cancer Genetics, Thyrocare Gulf collaborate to offer oncology based genomic solutions

2018-03-11 23:36:28

Datar Cancer Genetics has entered into a collaboration with Bahrain’s Thyrocare Gulf to offer their oncology based genomic solutions in the region. By Team ABLEDatar Cancer Genetics Limited has entered into a collaboration with Bahrain-based Thyrocare Gulf to offer their oncology based genomic solutions in the region. “Our relationship with Thyrocare Gulf expands our footprint into the Middle

Read more